Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Mazzaferro

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
Transplantation Proceedings|March 27, 2001
Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatmentV Mazzaferro, A Tagger, M Schiavo, et al.
The British Journal of Surgery|January 12, 2020
Risk-adjusted benchmarks in laparoscopic liver surgery in a national cohortN Russolillo, L Aldrighetti, U Cillo, et al.
Hepatology (Baltimore, Md.)|April 1, 1991
Effect of cyclosporine on hepatic energy status and on fructose metabolism after portacaval shunt in dog as monitored by phosphorus-31 nuclear magnetic resonance spectroscopy in vivoL Rossaro, V Mazzaferro, C L Scotti-Foglieni, et al.
Hepatology (Baltimore, Md.)|March 8, 2000
Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantationG Perseghin, V Mazzaferro, L P Sereni, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|April 20, 2013
Malignant pheochromocytoma and paraganglioma: future considerations for therapyR Buzzoni, S Pusceddu, A Damato, et al.
Surgery|May 1, 1990
The hepatotropic influence of cyclosporineV Mazzaferro, K A Porter, C L Scotti-Foglieni, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1988
Does hyperprolactinemia affect hepatic regeneration independent of sex steroids?D Kahn, J S Gavaler, L Makowka, et al.
Transplantation Proceedings|February 1, 1997
Prophylaxis against HCV recurrence after liver transplantation: effect of interferon and ribavirin combinationV Mazzaferro, E Regalia, A Pulvirenti, et al.
The New England Journal of Medicine|June 29, 1989
Efficacy of liver transplantation in patients with primary biliary cirrhosisB H Markus, E R Dickson, P M Grambsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2014
Activity and safety of RAD001 (everolimus) in patients affected by biliary tract cancer progressing after prior chemotherapy: a phase II ITMO studyR Buzzoni, S Pusceddu, E Bajetta, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Transplantation Proceedings|March 27, 2001
Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatmentV Mazzaferro, A Tagger, M Schiavo, et al.
The British Journal of Surgery|January 12, 2020
Risk-adjusted benchmarks in laparoscopic liver surgery in a national cohortN Russolillo, L Aldrighetti, U Cillo, et al.
Hepatology (Baltimore, Md.)|April 1, 1991
Effect of cyclosporine on hepatic energy status and on fructose metabolism after portacaval shunt in dog as monitored by phosphorus-31 nuclear magnetic resonance spectroscopy in vivoL Rossaro, V Mazzaferro, C L Scotti-Foglieni, et al.
Hepatology (Baltimore, Md.)|March 8, 2000
Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantationG Perseghin, V Mazzaferro, L P Sereni, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|April 20, 2013
Malignant pheochromocytoma and paraganglioma: future considerations for therapyR Buzzoni, S Pusceddu, A Damato, et al.
Surgery|May 1, 1990
The hepatotropic influence of cyclosporineV Mazzaferro, K A Porter, C L Scotti-Foglieni, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1988
Does hyperprolactinemia affect hepatic regeneration independent of sex steroids?D Kahn, J S Gavaler, L Makowka, et al.
Transplantation Proceedings|February 1, 1997
Prophylaxis against HCV recurrence after liver transplantation: effect of interferon and ribavirin combinationV Mazzaferro, E Regalia, A Pulvirenti, et al.
The New England Journal of Medicine|June 29, 1989
Efficacy of liver transplantation in patients with primary biliary cirrhosisB H Markus, E R Dickson, P M Grambsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2014
Activity and safety of RAD001 (everolimus) in patients affected by biliary tract cancer progressing after prior chemotherapy: a phase II ITMO studyR Buzzoni, S Pusceddu, E Bajetta, et al.
Pageof 12